苄氟噻嗪结构式
|
常用名 | 苄氟噻嗪 | 英文名 | bendroflumethiazide |
|---|---|---|---|---|
| CAS号 | 73-48-3 | 分子量 | 421.415 | |
| 密度 | 1.5±0.1 g/cm3 | 沸点 | 602.1±65.0 °C at 760 mmHg | |
| 分子式 | C15H14F3N3O4S2 | 熔点 | 205-207ºC | |
| MSDS | 中文版 美版 | 闪点 | 318.0±34.3 °C |
苄氟噻嗪用途苯卓氟甲肼是一种口服利尿剂。苯卓氟甲基噻嗪是一种抗高血压药物。苯卓氟甲基噻嗪在动脉性高血压疾病的研究中具有潜力[1]。 |
| 中文名 | 苄氟噻嗪 |
|---|---|
| 英文名 | bendroflumethiazide |
| 中文别名 | 3-苄基-3,4-二氢-6-(三氟甲基)-2H-1,2,4-苯并噻二嗪-7-磺酰胺-1,1-二氧化物 | 3-苄基-3,二氢-6-(三氟甲基)-2H-1,2,4-苯并噻二嗪-7-氨基磺酰-1,1-二氧化物 |
| 英文别名 | 更多 |
| 描述 | 苯卓氟甲肼是一种口服利尿剂。苯卓氟甲基噻嗪是一种抗高血压药物。苯卓氟甲基噻嗪在动脉性高血压疾病的研究中具有潜力[1]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 沸点 | 602.1±65.0 °C at 760 mmHg |
| 熔点 | 205-207ºC |
| 分子式 | C15H14F3N3O4S2 |
| 分子量 | 421.415 |
| 闪点 | 318.0±34.3 °C |
| 精确质量 | 421.037781 |
| PSA | 135.12000 |
| LogP | 2.07 |
| 外观性状 | 白色固体 |
| 蒸汽压 | 0.0±1.7 mmHg at 25°C |
| 折射率 | 1.584 |
| 储存条件 | 通风低温干燥 |
| 水溶解性 | Practically insoluble in water, freely soluble in acetone, soluble in ethanol (96 per cent). |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 2 |
| RTECS号 | DK8225000 |
|
Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. I: Investigation of mobile phase and MS conditions.
Anal. Chim. Acta 853 , 637-46, (2014) The conditions for the analysis of selected doping substances by UHPSFC-MS/MS were optimized to ensure suitable peak shapes and maximized MS responses. A representative mixture of 31 acidic and basic ... |
|
|
Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: Analysis of biological samples.
Anal. Chim. Acta 853 , 647-59, (2014) The potential and applicability of UHPSFC-MS/MS for anti-doping screening in urine samples were tested for the first time. For this purpose, a group of 110 doping agents with diverse physicochemical p... |
|
|
Binding of diuretic antihypertensive bendroflumethiazide to human serum albumin studied by ¹⁹F nuclear magnetic resonance method.
Eur. J. Pharm. Sci. 45(1-2) , 195-200, (2012) Simultaneous specific and nonspecific binding of bendroflumethiazide (BFZ) to human serum albumin (HSA) and concentration profile of BFZ in HSA buffer (pH 7.40) solution were investigated by ¹⁹F nucle... |
| 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide |
| Pluryl |
| benzoflumethiazide |
| 3-Benzyl-6-(trifluorométhyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxyde |
| Bendrofluazide |
| 3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1λ<sup>6</sup>,2,4-benzothiadiazine-7-sulfonamide |
| Naturetin |
| 3,4-Dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide |
| 3-Benzyl-3,4-dihydro-7-sulfamyl-6-trifluoromethyl-1,2,4-benzothiadiazine 1,1-Dioxide |
| 3-Benzyl-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide |
| Benzydroflumethiazide |
| Centyl |
| Benzylrodiuran |
| Berkozide |
| bendroflumethiazide |
| bendroflumethazide |
| Neo-naclex |
| Naturine |
| 3-(Phenylmethyl)-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide |
| bendroflumetazide |
| Aprinox |
| T66 BSWM EM DHJ D1R& HXFFF ISZW |
| Salures |
查看所有供应商和价格请点击：
CAS号1087345-31-0
CAS号1245935-40-3